Cocrystal Pharma, Inc. (COCP) Just Reaches All-Time Low?

April 17, 2018 - By Vivian Park

Cocrystal Pharma, Inc. (NASDAQ:COCP) Logo

The stock of Cocrystal Pharma, Inc. (NASDAQ:COCP) reached all time low today, Apr, 17 and still has $3.88 target or 3.00 % below today’s $4.00 share price. This indicates more downside for the $97.56 million company. This technical setup was reported by Barchart.com. If the $3.88 PT is reached, the company will be worth $2.93M less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only.

The stock decreased 5.04% or $0.212 during the last trading session, reaching $3.998. About 34,086 shares traded or 212.23% up from the average. Cocrystal Pharma, Inc. (NASDAQ:COCP) has 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Cocrystal Pharma, Inc. focuses on developing novel medicines for use in the treatment of human viral diseases. The company has market cap of $97.56 million. It has developed proprietary structure drug design and antiviral nucleoside chemistry to create antiviral drug candidates. It currently has negative earnings. The firm is developing antiviral drug candidates designed to transform the treatment and/or prophylaxis of hepatitis C virus, influenza virus, and norovirus.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.